The Role of Cell-Free Plasma DNA in Patients with Cardiorenal Syndrome Type 1

Conclusion: Our study explores the premise of cfDNA as a marker for apoptosis and inflammation in CRS type 1 patients. cfDNA could potentially serve as an index for noninvasive monitoring of tissue damage and apoptosis in patients with AKI induced by AHF.Cardiorenal Med
Source: Cardiorenal Medicine - Category: Urology & Nephrology Source Type: research